Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2231010420
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coulam, C. H.
Right arrow Articles by Sommer, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coulam, C. H.
Right arrow Articles by Sommer, F. G.
(Radiology 2002;223:76-82.)
© RSNA, 2002


Experimental Studies

Noninvasive Measurement of Extraction Fraction and Single-Kidney Glomerular Filtration Rate with MR Imaging in Swine with Surgically Created Renal Arterial Stenoses1

Curtis H. Coulam, MD, Jin H. Lee, BS, Kristin L. Wedding, PhD, Daniel M. Spielman, PhD, Norbert J. Pelc, ScD, Stephen T. Kee, MD, Bradley B. Hill, MD, Donna M. Bouley, PhD, DVM, Geraldine C. Derby, RN, BSN, Bryan D. Myers, MB, BCh, Anne M. Sawyer-Glover, RT and F. Graham Sommer, MD

1 From the Departments of Radiology (C.H.C., K.L.W., D.M.S., N.J.P., S.T.K., A.M.S.G., F.G.S.), Electrical Engineering (J.H.L.), Surgery (B.B.H.), and Comparative Medicine (D.M.B.), and the Division of Nephrology (G.C.D., B.D.M.), Stanford University School of Medicine, 300 Pasteur Dr, H-1307, Stanford, CA 94305. From the 2000 RSNA scientific assembly. Received February 5, 2001; revision requested March 20; final revision received August 22; accepted October 10. Supported in part by NIH grants R01-DK48051 and T32-CA90695. Address correspondence to F.G.S. (e-mail: gsommer@stanford.edu).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To test whether magnetic resonance (MR) imaging enables accurate measurement of extraction fraction (EF) in swine with unilateral renal ischemia and to evaluate effects of renal arterial stenosis on EF and single-kidney glomerular filtration rate.

MATERIALS AND METHODS: High-grade unilateral renal arterial stenoses were surgically created in eight pigs. Direct measurements of renal venous and arterial inulin concentration provided reference standard estimates of single-kidney EF. Pigs were imaged with a 1.5-T imager to estimate EF, renal blood flow, and glomerular filtration rate. A breath-hold inversion-recovery spiral sequence was used to measure T1 of blood in the infrarenal inferior vena cava and renal veins after intravenous administration of gadopentetate dimeglumine, and these data were used to calculate EF. Cine-phase contrast material–enhanced imaging of the renal arteries provided quantitative renal blood flow measurements. Bilateral single-kidney glomerular filtration rate was then determined: glomerular filtration rate = renal blood flow x (1 - hematocrit level) x EF.

RESULTS: A statistically significant linear correlation was found between EF, as determined with MR imaging, and inulin (r = 0.77). As compared with kidneys without renal arterial stenosis, kidneys with renal arterial stenosis showed 50% (0.14/0.28) EF reduction (P < .01) and 59% glomerular filtration rate reduction (P < .01).

CONCLUSION: MR imaging shows promise for in vivo measurement of EF and glomerular filtration rate, which may be useful in assessing the clinical importance of renal arterial stenosis.

© RSNA, 2002

Index terms: Animals • Kidney, function, 81.764 • Kidney, ischemia, 81.764 • Kidney, MR, 81.121412, 81.121413, 81.12143, 81.12144 • Kidney, stenosis or obstruction, 81.481 • Renal arteries, stenosis or obstruction, 961.729


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Atherosclerotic renal arterial occlusive disease is a common cause of both hypertension and progressive renal insufficiency (16). While current techniques, including magnetic resonance (MR) imaging, computed tomography (CT), and catheter angiography, can provide renal arterial anatomic information about the extent of renal arterial stenosis (RAS), renal physiologic information might also be useful for determining the clinical importance of renal vascular disease. An MR imaging–based technique to measure extraction of gadopentetate dimeglumine by the kidney, as well as glomerular filtration rate (GFR), has been described (7,8), but to our knowledge, the technique has yet to be used to study ischemia. In vivo measurement of extraction fraction (EF) with MR imaging makes use of the fact that diethylenetriaminepentacetic acid, or DTPA, is a marker of glomerular filtration (9) and that this acid tagged with gadolinium (gadopentetate dimeglumine) shortens the T1 relaxation time of blood (7,8,10,11). If accurate in depicting renal function, MR imaging as a single examination should have the potential to better guide treatment of RAS by providing both anatomic and physiologic information.

The purpose of our study was to test whether MR imaging can enable accurate measurement of EF in swine with unilateral renal ischemia and to evaluate the effects of RAS on EF and single-kidney GFR.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Between January and May 2000, unilateral left RAS were surgically created in eight young Yorkshire swine, and renal function was subsequently measured with both a standard inulin EF (EFIN) technique and an MR imaging technique. Pigs were selected because of the similarities between human and porcine kidneys (12,13). The study was approved by our institution’s animal care and use committee. Each animal underwent the surgical procedure, EFIN determination, and MR imaging examination to measure renal blood flow (RBF) and EF of gadopentetate dimeglumine (EFGD).

Surgery and EFIN
On the morning of the study, each animal was premedicated with 5–7 mg per kilogram of body weight telazol and 0.05 mg/kg atropine intramuscularly, intubated, and mechanically ventilated. General anesthesia was maintained with isoflurane (1%–3%) and oxygen (1.5 L/min) for the duration of the procedure, and the anesthetized animals were continuously monitored with pulse oximetry and temperature probes. A 6-F multiple-side-hole suprapubic catheter was placed in the bladder. Angiographic catheters were placed in the aorta and both renal veins by using the Seldinger technique, with vascular access via the unilateral common femoral artery and bilateral common femoral veins. All pigs underwent volume expansion with 500-mL Lactate Ringers to ensure adequate hydration. The pigs were then given an intravenous bolus of 1 g inulin (Questcor Pharmaceuticals, Hayward, Calif), followed with continuous 14 mL/h infusion of a 9% solution of inulin by using an infusion pump (Ivion, Broomfield, Colo). The left main renal artery was surgically exposed, and a 6-mm inflatable cuff occluder (In Vivo Metrics, Healdsburg, Calif) was applied proximal to the hilar branches. A stenosis was created by reducing vessel diameter by 75%–90%, as judged at subsequent digital subtraction angiography (Fig 1).



View larger version (125K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Thin-slab maximum intensity projection image from coronal contrast-enhanced three-dimensional spoiled gradient-echo MR angiography (3.6/1.0; flip angle, 25°) shows surgically created high-grade stenosis (arrow) of porcine left renal artery. A 75%-90% stenosis was surgically created and confirmed with digital subtraction angiography (images not shown).

 
After surgery, blood from the aorta and renal veins was sampled to determine EFIN (14), EFIN = (AoIN - RVIN)/AoIN, AoIN is aortic (systemic) concentration of inulin, and RVIN is renal venous concentration of inulin. Inulin measurements constituted the reference estimate of single-kidney EF, for comparison with values of EFGD determined with MR imaging.

The time to perform surgery and collect blood samples was approximately 4 hours. The anesthetized animals were then transported to the MR imaging suite. Imaging time was approximately 1 hour, and at completion of MR imaging, the animals were killed. Total anesthesia time was approximately 6 hours.

MR Imaging Technique
The animals were imaged with a 1.5-T system (GE Signa CV/i; GE Medical Systems, Milwaukee, Wis), with a maximum gradient strength of 40 mT/m and a maximum gradient slew rate of 150 mT/m/msec. A quadrature receive coil was positioned around the torso of the pig, centered over the kidneys. The body coil was used for radio-frequency transmission, and all images were acquired during suspended ventilation to minimize motion artifacts. For sequences requiring cardiac gating, a plethysmograph was attached to the pig’s tail.

Anatomic information from the renal vessels and kidneys was obtained with multiphasic 20–40-mL gadopentetate dimeglumine–(intravenously administered Magnevist; Berlex Laboratories, Wayne, NJ) enhanced coronal three-dimensional spoiled gradient-echo sequence (15): 3.6/1.0 (repetition time [TR] msec/echo time [TE] msec); flip angle, 25°; receiver bandwidth, ±125 kHz; fractional echo; one signal acquired; field of view, 32 x 32 x 12 cm; in-plane matrix, 512 x 192; section thickness, 2–3 mm, with zero order filling in z, resulting in section spacing of 1.0–1.5 mm; and imaging time, 30 seconds. The imaging volume, prescribed graphically from a transverse localizer, encompassed the aorta and inferior vena cava (IVC) anteriorly and the kidneys posteriorly. Two phases, arterial and venous, were acquired sequentially by using an imaging delay of 8–16 seconds for the first phase. The aorta, infrarenal IVC, and renal vessels were localized from the three-dimensional spoiled gradient-echo sequence, and multiple (at least two) subsequent sets of T1 relaxation and flow measurements were obtained, as described next.

The T1 relaxation sequence was written at our institution for this project (16) (Fig 2). To minimize pulsatility effects, cardiac gating was used, and the image was acquired during suspended ventilation to minimize artifacts related to respiratory motion. The pulse sequence commenced with a nonselective 180° adiabatic inversion pulse triggered by systolic upstroke. After the inversion pulse, a series of four water-selective section-selective (spectral-spatial) 90° radio-frequency pulse/spiral readouts were executed. The first and third readout pulses were synchronized to systolic triggers (the first was immediately after the inversion pulse), and the second and fourth readouts occurred after a user-defined delay from the systolic trigger. This delay time was chosen to result in approximately evenly spaced readout signals and thus depended on the animal’s heart rate, which was usually 70–110 bpm. For example, for a heart rate of 85 bpm, the R-R interval would be 700 msec, and readout signals would be acquired approximately 14, 364, 714, and 1,064 msec after the inversion pulse. Filling of k-space required 20 interleaved spirals per image and 40 cardiac cycles. The system was tuned to the center frequency of water. TR was every other heartbeat; TE, 6.7 msec; receiver bandwidth, ±100 kHz; one signal acquired; field of view, 30 x 30 cm; matrix, 200 x 200; section thickness, 5 mm; imaging time, 25–40 seconds. For spins replaced within the imaging section between 90° excitations (eg, flowing blood), this sequence yielded four measurements of the signal recovery after inversion, from which T1 could be calculated.



View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2. Diagram of spiral T1 relaxation pulse sequence. Gx, Gy, Gz = magnetic field gradients in x, y, and z directions, respectively; Rho, Theta = magnitude and phase, respectively, of radio-frequency pulse.

 
Because of the small size of the renal arteries, we found that T1 measurement in these vessels was very difficult. By assuming thorough mixing of gadopentetate dimeglumine in the blood pool, however, T1 values of either the aorta or infrarenal IVC are acceptable substitutes for systemic arterial blood T1 values (8,10). Accordingly, the IVC and aorta were imaged in a transverse plane below the level of the renal veins in six pigs, and the aorta above the level of the renal veins was imaged in two pigs. The renal veins were imaged in sagittal oblique planes orthogonal to their course (Fig 3). Since the T1 relaxation time of unenhanced blood is required to calculate EF with our technique, the T1 of blood was measured in the infrarenal IVC and/or aorta prior to gadopentetate dimeglumine administration. Gadopentetate dimeglumine was administered as a 20–40-mL intravenous bolus during three-dimensional spoiled gradient-echo acquisition, equilibrating in the blood pool before T1 relaxation sequences were performed. T1 values were then measured sequentially in the following order: IVC and aorta, left renal vein, right renal vein, and IVC and aorta again. This sequence was performed at least twice.



View larger version (159K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3. Coronal maximum intensity projection image from contrast-enhanced three-dimensional spoiled gradient-echo MR imaging (3.6/1.0; flip angle, 25°). Lines indicate imaging planes for spiral T1 relaxation measurements. Renal veins were imaged in all eight pigs. The aorta above (two pigs) and the IVC and aorta below (six pigs) the level of the renal veins were imaged to determine renal arterial input T1 values.

 
T1 values were computed at an off-line workstation (Sun Microsystems, Mountain View, Calif). A three-parameter (spin density, T1, fraction-inverted) exponential relaxation model was fit to the data sets of signal as a function of time by using Marquardt-Levenberg nonlinear least squares analysis (17) (Fig 4). Five regions of interest were placed in the vessel lumen, and the resultant T1 values were averaged, with care taken to exclude any portion of the vessel wall from the regions of interest. The regions of interest were placed with consensus of two authors (C.H.C., J.H.L.) and ranged in size from 17–88 mm2. Single-kidney EF was calculated with the formula: EFGD = (T1PRE/T1V)(T1V - T1A)/(T1PRE - T1A), where T1PRE is T1 of blood before gadopentetate dimeglumine administration, and T1V and T1A are T1 of blood in the renal vein and IVC and in the aorta, respectively, after gadopentetate dimeglumine administration. Linear interpolation between sequential T1A values was performed to compensate for nonsimultaneous measurements of T1 of blood in the renal veins and T1 of blood in the IVC and aorta.



View larger version (147K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4a. (a-d) Magnified views of left renal vein from spiral T1 relaxation sequence (water selective excitation; inversion pulse every other heartbeat, readout pulses at 14, 364, 714, and 1,064 msec; TE, 6.7 msec) and (e) corresponding phase-contrast image (8.1/3.7; velocity-encoding through plane, 100 cm/sec). (f) T1 relaxation curve derived from average pixel signal intensity in regions of interest (ellipses, a-d). Measured T1 TR is 294 msec.

 


View larger version (149K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4b. (a-d) Magnified views of left renal vein from spiral T1 relaxation sequence (water selective excitation; inversion pulse every other heartbeat, readout pulses at 14, 364, 714, and 1,064 msec; TE, 6.7 msec) and (e) corresponding phase-contrast image (8.1/3.7; velocity-encoding through plane, 100 cm/sec). (f) T1 relaxation curve derived from average pixel signal intensity in regions of interest (ellipses, a-d). Measured T1 TR is 294 msec.

 


View larger version (151K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4c. (a-d) Magnified views of left renal vein from spiral T1 relaxation sequence (water selective excitation; inversion pulse every other heartbeat, readout pulses at 14, 364, 714, and 1,064 msec; TE, 6.7 msec) and (e) corresponding phase-contrast image (8.1/3.7; velocity-encoding through plane, 100 cm/sec). (f) T1 relaxation curve derived from average pixel signal intensity in regions of interest (ellipses, a-d). Measured T1 TR is 294 msec.

 


View larger version (147K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4d. (a-d) Magnified views of left renal vein from spiral T1 relaxation sequence (water selective excitation; inversion pulse every other heartbeat, readout pulses at 14, 364, 714, and 1,064 msec; TE, 6.7 msec) and (e) corresponding phase-contrast image (8.1/3.7; velocity-encoding through plane, 100 cm/sec). (f) T1 relaxation curve derived from average pixel signal intensity in regions of interest (ellipses, a-d). Measured T1 TR is 294 msec.

 


View larger version (102K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4e. (a-d) Magnified views of left renal vein from spiral T1 relaxation sequence (water selective excitation; inversion pulse every other heartbeat, readout pulses at 14, 364, 714, and 1,064 msec; TE, 6.7 msec) and (e) corresponding phase-contrast image (8.1/3.7; velocity-encoding through plane, 100 cm/sec). (f) T1 relaxation curve derived from average pixel signal intensity in regions of interest (ellipses, a-d). Measured T1 TR is 294 msec.

 


View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4f. (a-d) Magnified views of left renal vein from spiral T1 relaxation sequence (water selective excitation; inversion pulse every other heartbeat, readout pulses at 14, 364, 714, and 1,064 msec; TE, 6.7 msec) and (e) corresponding phase-contrast image (8.1/3.7; velocity-encoding through plane, 100 cm/sec). (f) T1 relaxation curve derived from average pixel signal intensity in regions of interest (ellipses, a-d). Measured T1 TR is 294 msec.

 
EFGD measured with MR imaging was compared with inulin extraction by using linear-regression analysis and a paired t test with a linear mixed-effects model. EF values from the group of kidneys without RAS (right kidneys) were compared with those from the group with RAS (left kidneys) by using a paired t test.

Flow Quantification
Flow characterization and quantitation with cine-phase contrast-enhanced imaging is based on a relationship between measured phase shifts and flow velocity (18,19). The manufacturer’s two-dimensional segmented k-space cine-phase contrast-enhancement technique with view interpolation was used to acquire data for flow measurement from the renal arteries. Images were acquired during suspended ventilation, and imaging parameters were as follows: 8.1/3.7; bandwidth, ± 32 kHz; one signal acquired; field of view, 24–30 cm; matrix, 256 x 192; section thickness, 5 mm; flip angle, 20°; time frames per cardiac cycle, 20–24; views per frame per cardiac cycle, 4–8; velocity-encoding through-plane, 100–200 cm/sec; imaging time, 25–40 sec. At least one and usually two or three cine-phase contrast-enhanced images per vessel were obtained, and imaging planes were orthogonal to the renal artery being studied. The lower end of the velocity-encoding range was initially chosen and increased if aliasing occurred. The left main renal artery was imaged proximal to the surgical stenosis to avoid dephasing accompanying complex flow distal to the stenosis. Flow through the vessel of interest was computed at an off-line workstation (Sun Microsystems) by using previously described techniques (1923). Single-kidney GFR was calculated as: RPF = RBF x (1 - H) and GFR = RPF x EFGD, where RPF is single-kidney renal plasma flow and H is hematocrit level from a sample of pig blood.

Renal Volumes
To normalize RBF and GFR to kidney size, renal volumes were determined from MR imaging data. By using a workstation (Advantage Windows; GE Medical Systems), kidneys were segmented from a nephrographic phase of the three-dimensional spoiled gradient-echo sequence. Kidneys were manually traced by one author (C.H.C.), and the software automatically summed voxel volume in the segmented object. The rationale for normalizing RBF and GFR by renal volume is to compensate for differences in size among porcine kidneys (2426).

Normalized RBF and GFR values from kidneys without RAS (right kidneys) were compared with values from kidneys with RAS (left kidneys) by using a paired t test.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the eight pigs studied, acquisition of T1 measurement sequences was successful in six, including sampling of the infrarenal IVC, which was found necessary for satisfactory estimation of renal arterial input value of T1 (discussed subsequently). For these six animals (12 kidneys), the following results were observed: (a) Statistically significant linear correlation was seen between EF measured with MR imaging versus inulin (r = 0.77, P < .01) (Fig 5). Since each pig contributed a left and right kidney, there was the possibility of intrapig correlation. To account for this, we used a linear mixed-effects model, treating the individual pig as a random effect, MR imaging as the response, and EF determined with inulin clearance as the fixed linear effect. (b) Significantly reduced EF was seen in the ischemic left kidney, as compared with the right, for both MR imaging (EFGD in left kidney = 0.14 ± 0.06 [mean ± SD], EFGD in right kidney = 0.28 ± 0.05, P < .001, paired t test) (Fig 6) and inulin measurements (EFIN in left kidney = 0.22 ± 0.11; EFIN in right kidney = 0.33 ± 0.08, P < .05). (c) MR imaging EF measurements were lower than EFIN measurements (mean EFGD in all kidneys = 0.21; mean EFIN in all kidneys = 0.27; P = .01, paired t test); and (d) no significant difference was seen between MR imaging and inulin measurements of EF difference between nonischemic (right) and ischemic (left) kidneys (EFGD in right kidney - left kidney = 0.14 ± 0.05; mean EFIN in right kidney - left kidney = 0.11 ± 0.11; P = .56, paired t test).



View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5. Plot of single-kidney EF determined with inulin measurement and MR imaging. A statistically significant linear correlation between EF measured with MR imaging versus EFIN was found (r2 = 0.77). {blacktriangleup} = value observed in kidney without RAS (right kidneys), {blacksquare} = value observed in kidney with RAS (left kidneys).

 


View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6. Graphs show EFGD (EDTPA), RBF, and GFR, as determined with MR imaging. The left kidneys, which contain RAS, show significant decrease in EFGD, moderate decrease in RBF, and striking decrease in GFR, as compared with nonischemic right kidneys.

 
Of the eight pigs, one died in the MR imager before cine-phase contrast-enhanced flow sequences were performed. Aliasing in the renal arteries, unnoticed at the time of imaging, occurred in another pig. This resulted in six animals in which RBF was measured. As measured with cine–phase contrast-enhanced MR imaging, RBF normalized to renal volume decreased in kidneys with RAS (1.34 mL/min/mL ± 0.59), as compared with kidneys without RAS (1.67 mL/min/mL ± 0.33) (P = .07, paired t test) (Fig 6).

MR imaging measures of single-kidney GFR normalized to renal volume were significantly decreased in the ischemic kidneys (0.139 mL/min/mL ± 0.067), as compared with normal kidneys (0.340 mL/min/mL ± 0.085) (P < .01, paired t test) (Fig 6).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
There were two major goals of this study of a swine model of unilateral RAS. The first was to determine the potential of MR imaging for measuring renal EF in vivo. The second goal was to observe the effect of RAS on single-kidney GFR. To accomplish these goals, we implemented a method for measuring T1 in flowing blood to compute EFGD in vivo. The GFR could then be determined selectively in the ischemic and contralateral kidney, by using the product of EFGD and ipsilateral renal plasma flow.

The general technique of using renal arterial and venous T1 differences to determine the renal extraction of gadopentetate dimeglumine was described by Dumoulin et al (7) and Katzberg et al (11). More recently, Niendorf et al (8,10) were successful in measuring EF accurately in vivo in an animal model. In the present study, we used a T1 measurement sequence that uses breath holding, peripheral cardiac gating, adiabatic inversion, and interleaved spiral readouts. This differs from standard gradient-echo and segmented echo-planar gradient-echo sequences previously described for measuring T1 in flowing blood (8,27). Some of the potential advantages of the T1 measurement sequence used in the current study include the adiabatic inversion pulse to ensure homogeneous 180° inversion of all spins, spectral-spatial excitation pulses to eliminate off-resonance artifacts from fat, and efficient use of magnetic field gradients and excellent flow characteristics inherent to spiral acquisition.

When the infrarenal IVC was used to measure the T1 of renal arterial input, a statistically significant linear correlation existed between EF measured at MR imaging and EF measured by sampling each vessel directly for inulin concentration (r = 0.77). Both MR imaging and inulin techniques showed a statistically significant reduction of EF in kidneys with RAS (left kidneys), as compared with that in kidneys without RAS (right kidneys). It was noted that although there was reasonable linear correlation between EF measured with MR imaging and inulin concentrations, values obtained with MR imaging were approximately 22% (1.00–0.21/0.27) lower (P = .01). This result may be compared with those in swine without RAS in an investigation by Niendorf et al (8), in which a significant difference between MR imaging and inulin measurements of EF was not observed. This prior study differs from the present study in that blood sampling for inulin and MR imaging occurred simultaneously, whereas in the present study, blood sampling for inulin was completed before MR imaging. It is plausible that the additional anesthesia time between blood sampling and MR imaging was accompanied by declining GFR and filtration fraction in the pigs, leading to lower EF determinations observed during MR imaging than during inulin studies. Any progressive decrease in renal function may have particularly affected the acutely ischemic kidneys. To gain further insight into this possibility, subsequent investigations could either randomize the order of MR imaging with inulin measurement or perform them simultaneously if the MR imaging schedule could accommodate this.

MR imaging EF results were found to be highly variable when aortic T1 measurements were used to characterize renal arterial input; thus, only the infrarenal IVC determinations of T1 were used in all preceding determinations of EF. The reasons for unreliable T1 measurements from aortic data are unclear, although a plausible explanation would be insufficient flow between consecutive 90° readout pulses during the spiral T1 sequence. This may have occurred if two consecutive readouts occurred in the same diastole as a result of (a) prominent delay time between the systolic trigger and the first 90° readout pulse or (b) substantial time difference between aortic systole and peripheral capillary systolic pulse, measured with the plethysmograph attached to the animal’s tail. With sequential readout pulses occurring every 350 msec, blood flow in the vessel being studied needed only to be 14.3 mm/sec to achieve complete refreshment of spins in a 5-mm section, but if flow in diastole were insufficient to replace blood in the imaging section, signal loss from longitudinal magnetization suppression would occur. To gain insight into aortic flow, cine-phase contrast-enhanced imaging of two porcine aortas was performed and indeed showed a flow profile close to zero for much of diastole. This could be responsible for errors in T1 measurement in the aorta, as compared with those in the IVC.

With MR imaging measurements, single-kidney GFR (normalized to renal volume) was significantly decreased in ischemic kidneys (0.139 mL/min/mL ± 0.067) versus nonischemic kidneys (0.340 mL/min/mL ± 0.085) (P < .01). This represents a GFR reduction of 59% in kidneys with acutely created high-grade RAS. While the fact that renal function decreased in the ischemic kidney is not surprising, an interesting observation is that 75%–90% diameter stenosis resulted in mean RBF reduction of only 20% (1.00–1.34/1.67) but EF reduction of 50% (0.14/0.28), as measured with MR imaging. A similar pattern of only mildly reduced renal plasma flow in the face of postischemic acute renal allograft failure in patients was recently observed by Corrigan et al (28). The implication of these results is that reduction of ipsilateral kidney GFR accompanying acute renal arterial obstruction may be predominantly governed by decreased hydrostatic filtration pressure rather than by absolute lack of blood flow. Of note, however, is that most renal arterial occlusive disease is chronic and develops slowly, such that different pathophysiology may be present in the setting of chronic RAS. Published data on MR imaging blood flow in stenotic human renal arteries, in fact, indicates that a more substantial reduction in renal flow accompanies RAS than was seen in our acute swine model (29). Further investigation of the relationship between chronic RAS and single-kidney GFR is needed to address this difference.

MR imaging, CT, catheter angiography, ultrasonography, and nuclear medicine have all been used in the evaluation of RAS. While all these techniques have their roles, none would appear to have potential for providing high-spatial-resolution anatomic detail of the renal arteries and parenchyma, combined with accurate measurement of physiologic parameters, including RBF, EF, and single-kidney GFR, which MR imaging might provide in a single examination. Studies (30,31) have shown MR angiography to be greater than 95% accurate in diagnosing RAS. As noted previously, the present and prior studies show considerable promise for renal EF measurement, exploiting arteriovenous T1 differences caused by renal extraction of gadopentetate dimeglumine. While subsequent measurement of GFR requires knowledge of both EF and RBF, a number of studies (21,26,32,33) have shown cine-phase contrast-enhanced MR imaging to be accurate in measuring RBF, allowing calculation of the critical functional parameter, single-kidney GFR, from in vivo MR imaging data. The ability to make such physiologic measurements with MR imaging, in combination with the widespread availability and favorable safety profile of gadopentetate dimeglumine, make the described technique ideal for noninvasive measurement of GFR.

Practical application: Atherosclerotic RAS is a common disease that may lead to hypertension and/or renal insufficiency. Determining the appropriate management of RAS, however, remains controversial. It is difficult to know whether visualized RAS actually causes hypertension or azotemia in a given individual. It has been noted, for example, that revascularization of radiographically detected RAS leads to significant improvement in renal function in only a minority of cases (1,2) and that balloon angioplasty for hypertension was little better than medical treatment alone in one multicenter trial (34). Knowledge of individual kidney GFR, obtained during a more comprehensive MR imaging examination in which both renal anatomic and physiologic information was evaluated, as has been previously advocated by Ros et al (35), would appear to have great potential for noninvasive renal diagnosis. Ultimately, such a comprehensive renal MR imaging examination could prove useful in accurately selecting those patients with RAS who are most likely to benefit from renal revascularization.


    ACKNOWLEDGMENTS
 
The authors thank Bradley J. Betts, PhD, and Trevor Hastie, PhD, for statistical analysis, and Thomas J. Brosnan, PhD, and Marcus T. Alley, PhD, for technical and analytical support.


    FOOTNOTES
 
Abbreviations: EF = extraction fraction, EFGD = EF of gadopentetate dimeglumine, EFIN = EF of inulin, GFR = glomerular filtration rate, IVC = inferior vena cava, RAS = renal arterial stenosis, RBF = renal blood flow

Author contributions: Guarantors of integrity of entire study, F.G.S., C.H.C.; study concepts, C.H.C., F.G.S., N.J.P., D.M.S.; study design, C.H.C., F.G.S., N.J.P.; literature research, C.H.C., F.G.S.; experimental studies, all authors; data acquisition, C.H.C., J.H.L., K.L.W., D.M.S., N.J.P., S.T.K., B.B.H., D.M.B., G.C.D., A.M.S.G., F.G.S.; data analysis/interpretation, C.H.C., F.G.S., J.H.L., D.M.B., B.D.M.; statistical analysis, C.H.C.; manuscript preparation, C.H.C.; manuscript definition of intellectual content and revision/review, C.H.C., F.G.S.; manuscript editing, C.H.C., F.G.S., N.J.P.; manuscript final version approval, F.G.S.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Textor SC. Revascularization in atherosclerotic renal artery disease. Kidney Int 1998; 53:799-811.[Medline]
  2. Textor SC, Canzanello VJ. Radiographic evaluation of the renal vasculature. Curr Opin Nephrol Hypertens 1996; 5:541-551.[CrossRef][Medline]
  3. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993; 118:712-719.[Abstract/Free Full Text]
  4. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48:1936- 1945.[Medline]
  5. Dunnick NR, Sfakianakis GN. Screening for renovascular hypertension. Radiol Clin North Am 1991; 29:497-510.[Medline]
  6. Canzanello VJ, Textor SC. Noninvasive diagnosis of renovascular disease. Mayo Clin Proc 1994; 69:1172-1181.[Medline]
  7. Dumoulin CL, Buonocore MH, Opsahl LR, et al. Noninvasive measurement of renal hemodynamic functions using gadolinium enhanced magnetic resonance imaging. Magn Reson Med 1994; 32:370-378.[Medline]
  8. Niendorf ER, Grist TM, Lee FT, Jr, Brazy PC, Santyr GE. Rapid in vivo measurement of single-kidney extraction fraction and glomerular filtration rate with MR imaging. Radiology 1998; 206:791-798.[Abstract/Free Full Text]
  9. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28:830-838.[Medline]
  10. Niendorf ER, Grist TM, Frayne R, Brazy PC, Santyr GE. Rapid measurement of Gd-DTPA extraction fraction in a dialysis system using echo-planar imaging. Med Phys 1997; 24:1907-1913.[CrossRef][Medline]
  11. Katzberg RW, Dumoulin CL, Buonocore MA, Opsahl LR, Darrow RD, Morris TW. Noninvasive measurement of renal hemodynamic functions using gadolinium-enhanced magnetic resonance imaging. Invest Radiol 1994; 29(suppl 2):S123-S126.
  12. Dantzler WH. Comparative physiology of the vertebrate kidney New York, NY: Springer-Verlag, 1989.
  13. Yokota SD, Benyajati S, Dantzler WH. Comparative aspects of glomerular filtration in vertebrates. Ren Physiol 1985; 8:193-221.[Medline]
  14. Battilana C, Shang H, Olshen R, Wexler L, Myers B. PAH extraction and estimation of plasma flow in diseased human kidneys. Am J Physiol 1991; 261(4 pt 2):F726-F733.[Abstract/Free Full Text]
  15. Alley MT, Shifrin RY, Pelc NJ, Herfkens RJ. Ultrafast contrast-enhanced three-dimensional MR angiography: state of the art. RadioGraphics 1998; 18:273-285.[Abstract]
  16. Fredrickson JO, Sommer FG, Pelc NJ. Measurement of Gd-DTPA concentration in flowing blood with MRI (abstr) In: Proceedings of the Seventh Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1999; 1204.
  17. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes: the art of science computing New York, NY: Cambridge University Press, 1986.
  18. Pelc N, Herfkens R, Shimakawa A, Enzmann D. Phase contrast cine magnetic resonance imaging. Magn Reson Q 1991; 7:229-254.[Medline]
  19. Pelc N, Sommer F, Li K, Brosnan T, Herfkens R, Enzmann D. Quantitative magnetic resonance flow imaging. Magn Reson Q 1994; 10:125-147.[Medline]
  20. Hofman MB, Visser FC, van Rossum AC, Vink QM, Sprenger M, Westerhof N. In vivo validation of magnetic resonance blood volume flow measurements with limited spatial resolution in small vessels. Magn Reson Med 1995; 33:778-784.[Medline]
  21. Debatin JF, Ting RH, Wegmuller H, et al. Renal artery blood flow: quantitation with phase-contrast MR imaging with and without breath holding. Radiology 1994; 190:371-378.[Abstract/Free Full Text]
  22. Pelc N, Sommer F, Enzmann D, Pelc L, Glover G. Accuracy and precision of phase-contrast flow measurements (abstr). Radiology 1991; 181(P):189.[Abstract/Free Full Text]
  23. Tang C, Blatter D, Parker D. Accuracy of phase-contrast flow measurements in the presence of partial-volume effects. J Magn Reson Imaging 1993; 3:377-385.[Medline]
  24. Lerman L, Flickinger A, Sheedy PN, Turner S. Reproducibility of human kidney perfusion and volume determinations with electron beam computed tomography. Invest Radiol 1996; 31:204-210.[CrossRef][Medline]
  25. Lerman LO, Taler SJ, Textor SC, Sheedy PF, II, Stanson AW, Romero JC. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int 1996; 49:846-854.[Medline]
  26. Sommer G, Corrigan G, Fredrickson J, et al. Renal blood flow: measurement in vivo with rapid spiral MR imaging. Radiology 1998; 208:729-734.[Abstract/Free Full Text]
  27. Look D, Locker D. Time saving in measurement of NMR and EPT relaxation times. Rev Sci Instr 1970; 41:250-251.[CrossRef]
  28. Corrigan G, Ramaswamy D, Kwon O, et al. PAH extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol 1999; 277:F312-F318.[Abstract/Free Full Text]
  29. Binkert CA, Hoffman U, Leung DA, Matter HG, Schmidt M, Debatin JF. Characterization of renal artery stenoses based on magnetic resonance renal flow and volume measurements. Kidney Int 1999; 56:1846-1854.[CrossRef][Medline]
  30. Postma C, Joosten F, Rosenbusch G, Thien T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J Hypertens 1997; 10:957-963.[CrossRef][Medline]
  31. Thornton J, O’Callaghan J, Walshe J, O’Brien E, Varghese JC, Lee MJ. Comparison of digital subtraction angiography with gadolinium-enhanced magnetic resonance angiography in the diagnosis of renal artery stenosis. Eur Radiol 1999; 9:930-934.[CrossRef][Medline]
  32. Debatin J, Leung D, Wildermuth S, Botnar R, Felblinger J, McKinnon G. Flow quantitation with echo-planar phase-contrast velocity mapping: in vitro and in vivo evaluation. J Magn Reson Imaging 1995; 5:656-662.[Medline]
  33. Myers BD, Sommer FG, Li K, et al. Determination of blood flow to the transplanted kidney: a novel application of phase-contrast, cine magnetic resonance imaging. Transplantation 1994; 57:1445-1450.[Medline]
  34. van Jaarsveld B, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis: Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342:1007-1014.[Abstract/Free Full Text]
  35. Ros PR, Gauger J, Stoupis C, et al. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate. AJR Am J Roentgenol 1995; 165:1447-1451.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
HypertensionHome page
J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo
Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis
Hypertension, February 1, 2008; 51(2): 466 - 473.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. K. Park, T. K. Rhee, T. A. Cashen, W. Shin, B. E. Schirf, J. A. Gehl, A. C. Larson, P. V. Prasad, D. Li, T. J. Carroll, et al.
Renal Artery Stenosis in Swine: Feasibility of MR Assessment of Renal Function during Percutaneous Transluminal Angioplasty
Radiology, July 1, 2007; 244(1): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. S. Lee, H. Rusinek, L. Bokacheva, A. J. Huang, N. Oesingmann, Q. Chen, M. Kaur, K. Prince, T. Song, E. L. Kramer, et al.
Renal function measurements from MR renography and a simplified multicompartmental model
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1548 - F1559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. V. Prasad
Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F958 - F974.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. Sommer, E. W. Olcott, L. C. Chow, R. R. Saket, and P. Schraedley-Desmond
Measurement of Renal Extraction Fraction with Contrast-enhanced CT
Radiology, September 1, 2005; 236(3): 1029 - 1033.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
V. S. Lee, H. Rusinek, M. E. Noz, P. Lee, M. Raghavan, and E. L. Kramer
Dynamic Three-dimensional MR Renography for the Measurement of Single Kidney Function: Initial Experience
Radiology, April 1, 2003; 227(1): 289 - 294.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coulam, C. H.
Right arrow Articles by Sommer, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coulam, C. H.
Right arrow Articles by Sommer, F. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE